Core Laboratories Inc. (CLB) stock
CLBNYSEOil & Gas Field Services, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 11/300% above fair value
$8.39−0.06 (-0.71%)
Close on Nov 17, 2026Market cap $384.46MP/E 24.7Yield 0.48%
Core Laboratories operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Core Laboratories's operating income for the twelve months ending Sep 30, 2026 was $38.94M, down 29.0% year over year. For fiscal 2025 it was $56.47M, down 3.6% from the year before. The highest annual figure on record is $58.56M in fiscal 2024.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $56.47M | -3.6% |
| FY2024 | Dec 31, 2024 | $58.56M | +7.2% |
| FY2023 | Dec 31, 2023 | $54.64M | +31.6% |
| FY2022 | Dec 31, 2022 | $41.52M | -8.3% |
| FY2021 | Dec 31, 2021 | $45.26M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $12.07M | -42.3% |
| Q2 FY2026 | Jun 30, 2026 | $9.15M | -40.2% |
| Q1 FY2026 | Mar 31, 2026 | $1.89M | -57.3% |
| Q4 FY2025 | Dec 31, 2025 | $15.83M | +11.7% |
| Q3 FY2025 | Sep 30, 2025 | $20.93M | +5.7% |
| Q2 FY2025 | Jun 30, 2025 | $15.29M | -4.5% |
| Q1 FY2025 | Mar 31, 2025 | $4.42M | -48.5% |
| Q4 FY2024 | Dec 31, 2024 | $14.17M | -2.8% |
| Q3 FY2024 | Sep 30, 2024 | $19.80M | +35.0% |
| Q2 FY2024 | Jun 30, 2024 | $16.01M | -15.3% |
| Q1 FY2024 | Mar 31, 2024 | $8.57M | +32.2% |
| Q4 FY2023 | Dec 31, 2023 | $14.58M | -6.6% |
| Q3 FY2023 | Sep 30, 2023 | $14.67M | +0.2% |
| Q2 FY2023 | Jun 30, 2023 | $18.91M | +62.3% |
| Q1 FY2023 | Mar 31, 2023 | $6.48M | – |
| Q4 FY2022 | Dec 31, 2022 | $15.62M | – |
| Q3 FY2022 | Sep 30, 2022 | $14.65M | – |
| Q2 FY2022 | Jun 30, 2022 | $11.65M | – |
See a number that looks wrong?